BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33649845)

  • 1. Effects of m6A modifications on signaling pathways in human cancer (Review).
    Liu F; Su X
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of m6A RNA methylation in cardiovascular disease (Review).
    Qin Y; Li L; Luo E; Hou J; Yan G; Wang D; Qiao Y; Tang C
    Int J Mol Med; 2020 Dec; 46(6):1958-1972. PubMed ID: 33125109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant Regulation of mRNA m⁶A Modification in Cancer Development.
    Luo J; Liu H; Luan S; He C; Li Z
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149601
    [No Abstract]   [Full Text] [Related]  

  • 4. The m
    Uddin MB; Wang Z; Yang C
    Mol Cancer; 2021 Apr; 20(1):61. PubMed ID: 33814008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of m6A RNA methylation in cancer metabolism.
    An Y; Duan H
    Mol Cancer; 2022 Jan; 21(1):14. PubMed ID: 35022030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physio-pathological effects of m6A modification and its potential contribution to melanoma.
    Liao Y; Han P; Zhang Y; Ni B
    Clin Transl Oncol; 2021 Nov; 23(11):2269-2279. PubMed ID: 34105069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functions of N6-methyladenosine and its role in cancer.
    He L; Li H; Wu A; Peng Y; Shu G; Yin G
    Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
    Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L
    Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of writers, erasers and readers within miRNA-related m6A modification in cancers.
    Feng H; Yuan X; Wu S; Yuan Y; Cui L; Lin D; Peng X; Liu X; Wang F
    Cell Prolif; 2023 Jan; 56(1):e13340. PubMed ID: 36162823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interplay between m6A RNA methylation and noncoding RNA in cancer.
    Ma S; Chen C; Ji X; Liu J; Zhou Q; Wang G; Yuan W; Kan Q; Sun Z
    J Hematol Oncol; 2019 Nov; 12(1):121. PubMed ID: 31757221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation.
    Yue Y; Liu J; He C
    Genes Dev; 2015 Jul; 29(13):1343-55. PubMed ID: 26159994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between m6A modification and miRNAs in malignant tumors.
    Han X; Guo J; Fan Z
    Cell Death Dis; 2021 Jun; 12(6):598. PubMed ID: 34108450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N
    Dorn LE; Lasman L; Chen J; Xu X; Hund TJ; Medvedovic M; Hanna JH; van Berlo JH; Accornero F
    Circulation; 2019 Jan; 139(4):533-545. PubMed ID: 30586742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression.
    Yi D; Wang R; Shi X; Xu L; Yilihamu Y; Sang J
    Oncol Rep; 2020 May; 43(5):1375-1386. PubMed ID: 32323801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
    Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
    Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential role of RNA N6-methyladenosine in Cancer progression.
    Wang T; Kong S; Tao M; Ju S
    Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of N6‑methyladenosine modification residues (Review).
    Zhu W; Wang JZ; Xu Z; Cao M; Hu Q; Pan C; Guo M; Wei JF; Yang H
    Int J Mol Med; 2019 Jun; 43(6):2267-2278. PubMed ID: 31017262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the N
    Scarrow M; Chen N; Sun G
    Crit Rev Biotechnol; 2020 Aug; 40(5):639-652. PubMed ID: 32321323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA m6A methylation regulators in endometrial cancer (Review).
    Shen S; Guo J; Lv N; Chen Q; Tong J
    Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36321774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.